Sign in
4

Changes in Ownership

Rapport Therapeutics, Inc. Filed Acc 0001193125-26-292546

Chief Operating Officer sold 10,000 shares at an average $41.58 ($415,798)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Gault Cheryl Chief Operating Officer 2026-06-30 Sale 10b5-1 −1,900 $40.09 $76,174 158,014 D
Gault Cheryl Chief Operating Officer 2026-06-30 Sale 10b5-1 −3,792 $41.39 $156,964 154,222 D
Gault Cheryl Chief Operating Officer 2026-06-30 Sale 10b5-1 −3,308 $42.17 $139,506 150,914 D
Gault Cheryl Chief Operating Officer 2026-06-30 Sale 10b5-1 −1,000 $43.15 $43,155 149,914 D
Open-market sales · 10,000 sh · avg $41.58 · $415,798
Loading xslF345X06/ownership.xml…